Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 30, 2016 07:00 ET | Source: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals to Present at 9th Annual LD Micro Main Event Investor Conference

NEW YORK, Nov. 30, 2016 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), which is developing a next-generation treatment for posttraumatic stress disorder (PTSD),...
November 30, 2016 06:05 ET | Source: Achillion Pharmaceuticals, Inc.

Achillion Announces Initiation of Patient Dosing by Janssen in a Global, Short Treatment-Duration Phase 2b Study of JNJ-4178 in Chronic HCV

- Janssen initiates dosing of patients in OMEGA-1: Phase 2b study evaluating six- and eight-week treatment durations with JNJ-4178, a 3DAA combination of odalasvir, simeprevir, and AL-335, for the...
November 29, 2016 09:45 ET | Source: Nymox Pharmaceutical Corporation

Nymox Reports Additional Positive Results From Completed Fexapotide BPH Phase 3 Studies Showing Significant Early Response and First-Line Efficacy

HASBROUCK HEIGHTS, N.J., Nov. 29, 2016 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce that new Phase 3 prospective randomized clinical trial results have...
November 29, 2016 09:00 ET | Source: AXIM Biotechnologies, Inc

AXIM® Biotech Files IP Application on Propietary Method to Extract High-Purity THC

Proprietary method in collaboration with Syncom B.V. will achieve a THC purity level of Greater than 95% NEW YORK, Nov. 29, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM®...
November 29, 2016 07:30 ET | Source: KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals Appoints Edward P. Feener, Ph.D. as Chief Scientific Officer

CAMBRIDGE, Mass. and PORTON DOWN, United Kingdom, Nov. 29, 2016 (GLOBE NEWSWIRE) -- KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), a clinical stage pharmaceutical company focused on the discovery,...
November 22, 2016 16:02 ET | Source: Achaogen Inc.

Achaogen Announces New Employment Inducement Grants

SOUTH SAN FRANCISCO, Calif., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials addressing multi-drug...
November 22, 2016 08:00 ET | Source: Innocoll Holdings plc

Innocoll Holdings plc Announces Third Quarter 2016 Financial and Operating Results and Provides Corporate Update

ATHLONE, Ireland, Nov. 22, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
November 22, 2016 07:30 ET | Source: KalVista Pharmaceuticals Ltd

KalVista Pharmaceuticals Announces Closing of Merger with Carbylan Therapeutics

—Combined company renamed KalVista Pharmaceuticals, Inc., listed on Nasdaq with ticker “KALV” — —Continued focus on development of protease inhibitors with multiple molecules for oral treatment of...
November 21, 2016 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals to Participate in the 28th Annual Piper Jaffray Healthcare Conference

CORAL GABLES, Fla., Nov. 21, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
November 18, 2016 07:00 ET | Source: Apricus Biosciences

Apricus Biosciences Provides Update on Vitaros NDA Following Receipt of FDA Feedback

SAN DIEGO, Nov. 18, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that...